- World Street Fundamentals -

Hong Kong - www.WorldStreetFundamentals.com released its industry report highlighting Inhibitex and Solar Capital. Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php?id=INHX+SLRC.

Markets are starting to step in the right direction, with the European Financial Stability Facility (EFSF) increasing from $600 billion to $1.4 trillion, a significant move to strengthen the safety net in place for Europe`s most troubled countries.

It is likely China and the IMF will contribute to the bailout fund, with Greece alone receiving $180 billion in fresh aid. The remainder of Greece`s obligations were halved in the process, with private bondholders of Greek debt settling at 50% -- allowing banks to recapitalize at a healthy 9% reserve and bring Greece`s debt burden down to 120% of GDP by 2020.

An important consideration is political commitment to this road map and probability of ongoing support for European Central Bank (ECB)`s recent deal. Currently the global community appears to be on point with ECB`s initiative, an outlook that should be sufficient to support markets around current levels.

World Street Fundamentals has highlighted Inhibitex for its current position within the healthcare industry. Inhibitex is a biopharmaceutical company focused on the development of differentiated anti-infective products to prevent or treat serious infections. The entire report on Inhibitex is available here: www.WorldStreetFundamentals.com/Report.php?id=INHX.

World Street has featured Solar Capital Ltd. for its development within the financial industry. The entire report on Solar Capital is available here: www.WorldStreetFundamentals.com/Report.php?id=SLRC.